Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 113 Neoplasm Metastasis 5 Carcinoma, Intraductal, Noninfiltrating 5 Polycystic Ovary Syndrome 4 Ovarian Neoplasms 4 Osteoporosis 4 Neoplasms 4 Infertility 4 Breast Neoplasms, Male 4 Arthralgia 4 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Pain 2 Leiomyosarcoma 2 Leiomyoma 2 Endometrial Neoplasms 2 Cystadenocarcinoma, Serous 2 Breast Carcinoma In Situ 2 Bone Diseases, Metabolic 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Cysts 1 Osteitis Deformans 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1

Interventions

tusamitamab ravtansine 1 nirogacestat 1 exemestane 1 Tamoxifen 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Docetaxel 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Breast Cancer Metastatic × Letrozole × Clear all

NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated

367 enrolled 30 charts

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡